Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 21:30:00 26/06/2024 BST 		5-day change 1st Jan Change
3.1 USD -4.32% Intraday chart for Tharimmune, Inc. -0.96% -59.40%
06-20 Tharimmune Prices $2.1 Million Private Placement of Common Shares, Warrants MT
06-18 Tharimmune, Inc. announced that it expects to receive $2.084162 million in funding from GRAVITAS Capital Advisors, Inc., SDS Capital Group and other investors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
THARIMMUNE, INC. Stock Tharimmune, Inc.
 2.55M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 116B
ARGENX SE Stock argenx SE
 27.03B -
BIONTECH SE Stock BioNTech SE
 20.36B -
GENMAB A/S Stock Genmab A/S
 16.43B
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Charts Tharimmune, Inc.
  5. Sector Chart